Want to see JP:6092 full AI Analyst Report?
6092 Stock Chart & Stats
¥598.00
-¥2.00(-0.33%)
At close: 4:00 PM EST
¥598.00
-¥2.00(-0.33%)
Day’s Range― - ―
52-Week Range¥550.00 - ¥1,009.00
Previous CloseN/A
Volume5.80K
Average Volume (3M)25.91K
Market Cap
¥5.84B
Enterprise Value¥12.49B
Total Cash (Recent Filing)¥4.04B
Total Debt (Recent Filing)¥10.65B
Price to Earnings (P/E)22.3
Beta0.57
Next Earnings
Aug 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.23%
Share Statistics
EPS (TTM)32.70
Shares Outstanding8,175,200
10 Day Avg. Volume21,320
30 Day Avg. Volume25,910
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)0.67
Price to Sales (P/S)0.49
P/FCF Ratio51.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth MomentumSustained double‑digit top‑line expansion through 2025–2026 indicates durable demand or share gains in its markets. Strong revenue momentum provides scale benefits, supports reinvestment capacity and gives management room to address margin pressures over a 2–6 month horizon.
Operating Cash Flow RecoveryA material rebound in operating cash flow demonstrates improved cash generation mechanics versus the prior year, easing short‑term liquidity strain. Consistent OCF supports working capital needs, capex and debt service, improving financial flexibility if sustained.
Growing Equity And Asset BaseAn expanding equity and asset base shows the company has been scaling and retaining capital, which underpins capacity to expand operations and absorb shocks. This provides structural support for longer‑term growth initiatives despite near‑term margin compression.
Bears Say
Weakening ProfitabilityA striking decline in net margin and net income despite rising revenue points to persistent cost pressures, mix deterioration or pricing weakness. Low profitability reduces internal funding, limits ability to deleverage and undermines sustainable returns to investors over the medium term.
Elevated Leverage Relative To MarginsDebt slightly above equity combined with compressed margins raises financial vulnerability. High leverage for the current earnings profile constrains strategic flexibility, amplifies interest expense risk and increases reliance on consistent cash generation to avoid solvency pressures.
Volatile And Thin Free Cash FlowLarge swings from deep cash burn to modest FCF indicate unstable cash conversion and possible working capital or high investment variability. Thin FCF relative to earnings limits debt reduction, capex funding and shareholder returns, making the business more fragile if earnings slip.
EnBio Holdings, Inc. News
6092 FAQ
What was EnBio Holdings, Inc.’s price range in the past 12 months?
EnBio Holdings, Inc. lowest stock price was ¥550.00 and its highest was ¥1009.00 in the past 12 months.
What is EnBio Holdings, Inc.’s market cap?
EnBio Holdings, Inc.’s market cap is ¥5.84B.
When is EnBio Holdings, Inc.’s upcoming earnings report date?
EnBio Holdings, Inc.’s upcoming earnings report date is Aug 14, 2026 which is in 12 days.
How were EnBio Holdings, Inc.’s earnings last quarter?
EnBio Holdings, Inc. released its earnings results on May 15, 2026. The company reported ¥40.83 earnings per share for the quarter, beating the consensus estimate of N/A by ¥40.83.
Is EnBio Holdings, Inc. overvalued?
According to Wall Street analysts EnBio Holdings, Inc.’s price is currently Overvalued.
Does EnBio Holdings, Inc. pay dividends?
EnBio Holdings, Inc. pays a Annually dividend of ¥24 which represents an annual dividend yield of 1.23%. See more information on EnBio Holdings, Inc. dividends here
What is EnBio Holdings, Inc.’s EPS estimate?
EnBio Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EnBio Holdings, Inc. have?
EnBio Holdings, Inc. has 8,175,200 shares outstanding.
What happened to EnBio Holdings, Inc.’s price movement after its last earnings report?
EnBio Holdings, Inc. reported an EPS of ¥40.83 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.109%.
Which hedge fund is a major shareholder of EnBio Holdings, Inc.?
Currently, no hedge funds are holding shares in JP:6092
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
EnBio Holdings, Inc.
EnBio Holdings, Inc. engages in the provision of soil pollution countermeasure services. It operates through the following segments: Soil Pollution Countermeasures, Brownfield Utilization, and Natural Energy. The Soil Pollution Countermeasures segment offers risk consulting services including investigation and construction of countermeasures for soil pollution. It also imports and sells equipment and purifying chemicals used for in situ investigation and purification. The Brownfield Utilization segment manages the buying, restoration, and reselling of contaminated lands. The Natural Energy segment handles the sale of power from natural energy. The company was founded on June 23, 1999 and is headquartered in Tokyo, Japan.
Technical Analysis
Paraca Inc.
―
SHIKIGAKU Co., Ltd.
―
Nakabayashi Co., Ltd.
―
PHYZ Holdings, Inc.
―
Biken Techno Corporation
―